Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORPORATION (BSX). Of the 22 guru strategies we follow, BSX rates highest using our Multi-Factor Investor model based on the ...

In the U.S., the ACURATE neo2 Aortic Valve System and the ACURATE Prime Aortic Valve System are investigational devices. Price Action: BSX stock is down 1.66% at $83.16 at last check Wednesday.

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORPORATION (BSX). Of the 22 guru strategies we follow, BSX rates highest using our Multi-Factor Investor model based on the ...

Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Call Transcript October 23, 2024 Boston Scientific Corporation ...

Neurology Sales Growth: 10% in Q3 2024. Endoscopy Sales Growth: 7% organically in Q3 2024. Boston Scientific Corp (NYSE:BSX) reported a 19% growth in operational sales and an 18% increase in organic ...

Endoscopy Sales Growth: 7% organically in Q3 2024. Boston Scientific Corp (NYSE:BSX) reported a 19% growth in operational sales and an 18% increase in organic sales for Q3 2024, exceeding their ...

Boston Scientific (NYSE:BSX) shares were down 5% in morning trading Wednesday following news that the company has paused a study for its new FARAPULSE Pulse Field Ablation system due to unforeseen ...

The street high price target from B of A Securities is $100.0, while the street low from Deutsche Bank is $78.0. Price Action: BSX stock is down 5.31% at $83.34 at the last check on Wednesday.

View upcoming earnings forecasts and in-depth analysis of company forecasts.

and has also served as chief business development officer at Nova Ltd in addition to spending 16 years in a variety of roles at Zurich Insurance Co Ltd. His responsibilities at the BSX include ...